Oberarzt
Klinik für Kardiologie
Dr. med. Lukas Keller
Nachricht sendenFunktion
Qualifikationen
Facharzt für Kardiologie FMH
Facharzt für Allgemeine Innere Medizin FMH
Interdisziplinärer Schwerpunkt Klinische Notfallmedizin SGNOR
Beruflicher Werdegang
Seit 11/2022
Oberarzt invasive und nicht-invasive Kardiologie
Klinik für Kardiologie, Kantonsspital Winterthur
09/2021 – 10/2022
Fellowship interventionelle Kardiologie
Institut universitaire de cardiologie et de pneumologie de Québec, Canada
01/2021 – 05/2021
Assistenzarzt Kardiale Bildgebung
Institut für Nuklearmedizin, Universitätsspital Zürich
05/2020 – 12/2020
Assistenzarzt Intensivmedizin
Institut für Intensivmedizin, Universitätsspital Zürich
11/2019 – 04/2020
Fellowship Interventionelle Kardiologie
Universitäres Herzzentrum, Universitätsspital Zürich
11/2017 – 10/2019
Assistenzarzt Allgemeine Kardiologie
Universitäres Herzzentrum, Universitätsspital Zürich
10/2016 – 09/2017
Assistenzarzt Notfallmedizin (SGNOR Curriculum)
Interdisziplinäres Notfallzentrum, Kantonsspital Baden
09/2015 – 08/2016
Assistenzarzt Notfallmedizin (SGNOR Curriculum)
Institut für Notfallmedizin, Universitätsspital Zürich
03/2015 – 08/2015
Assistenzarzt Intensivmedizin
Institut für Intensivmedizin, Universitätsspital Zürich
01/2013 – 01/2015
Assistenzarzt Allgemeine Innere Medizin
Medizinische Klinik, Zuger Kantonsspital
Ausbildungen und Diplome
- Doktorat (Doktor der Medizin)
Medizinische Fakultät, Universität Zürich - Eidgenössisches Examen in Humanmedizin
Medizinstudium Universität Zürich, Universität Bern und Universität Lund (Schweden) - United States Medical Licensing Examination (USMLE) Step 1, 2 und 3
- Maturität Schwerpunkt Biologie und Chemie
Freies Gymnasium Bern
Dissertation
“Cancer testis antigen expression in prostate cancer and humoral immune responses against cancer testis antigens“
Labor für Tumorimmunologie, Universitätsspital Zürich (Prof. Dr. A. Knuth)
High-Speed Onsite Deep-Learning Based FFR-CT Algorithm: Evaluation Using Invasive Angiography as Reference Standard
Giannopoulos AA, Keller L, Sepulcri D, Boehm R, Garefa C, Venugopal P, Mitra J, Ghose S, Deak P, Pack JD, Davis CL, Stähli BE, Stehli J, Pazhenkottil AP, Kaufmann PA, Buechel RR.
AJR Am J Roentgenol. 2023 May 3. doi: 10.2214/AJR.23.29156. Epub ahead of print. PMID: 37132550.
Angina in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
Keller LS, Nuche J, Avvedimento M, Real C, Pasos JF, Paradis JM, De Larochellière R, Poulin A, Kalavrouziotis D, Dumont E, Galhardo A, Mengi S, Mohammadi S, Cabau JR.
Rev Esp Cardiol (Engl Ed). 2023 May 1:S1885-5857(23)00113-5. English, Spanish. doi: 10.1016/j.rec.2023.04.004. Epub ahead of print. PMID: 37137426.
Syncope in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
Keller LS, Nuche J, Mesnier J, Farjat-Pasos J, Paradis JM, De Larochellière R, Mohammadi S, Kalavrouziotis D, Dumont E, Philippon F, Rodés-Cabau J.
Can J Cardiol. 2023 Fe 18:S0828-282X(23)00137-X. doi: 10.1016/j.cjca.2023.02.012.PMID:36806689.
Post-hoc motion correction for coronary computed tomography angiography without additional radiation dose – Improved image quality and interpretability for “free”
Degtiarova, G., Mikulicic, F., Vontobel, J., Garefa, C., Keller, L. S., Boehm, R., Ciancone, D., Gebhard, C., Pazhenkottil, A. P., Kaufmann, P. A., Buechel, R. R.
Imaging 2022 Nov 01; 14(2), 82-88. doi: 10.1556/1647.2022.00060
Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation
Mangner N, Brinkert M, Keller LS, Moriyama N, Hagemeyer D, Haussig S, Crusius L, Kobza R, Abdel-Wahab M, Laine M, Stortecky S, Pilgrim T, Nietlispach F, Ruschitzka F, Thiele H, Toggweiler S, Linke A.
EuroIntervention. 2022 Nov 28:EIJ-D-22-00521. doi: 10.4244/EIJ-D-22-00521. PMID: 36440479.
Association of N‐Terminal Pro‐B‐Type Natriuretic Peptide with Mortality in Elderly (≥ 80 Years) Patients Undergoing Percutaneous Coronary Intervention
Sager R, Keller LS, Stehli J, Jakob P, Michel J, Kasel M, Templin C, Stähli BE.
Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30365. PMID: 36040724.
Percutaneous Coronary Intervention Pre-TAVR: Current State of the Evidence
Keller LS, Panagides V, Mesnier J, Nuche J, Rodés-Cabau J.
Curr Cardiol Rep 2022 May 27. doi: /10.1007/s11886-022-01717-1
Depressive symptoms in patients after primary and secondary prophylactic ICD implantation
Ensslin C, Berg J, Hermes-Laufer J, Keller LS; Niederseer D, Pazhenkottil A, von Känel R, Schmied C.
Clin Res Cardiol. 2021 Nov 15. doi: 10.1007/s00392-021-01940-w. PMID: 34779916.
Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Vitamin K Antagonists or Direct Oral Anticoagulants.
Brinkert M, Mangner N, Moriyama N, Keller LS, Hagemeyer D, Crusius L, Lehnick D, Kobza R, Abdel-Wahab M, Laine M, Stortecky S, Pilgrim T, Nietlispach F, Ruschitzka F, Thiele H, Linke A, Toggweiler S.
JACC Cardiovasc Interv. 2021 Jan 25;14(2):135-144. doi: 10.1016/j.jcin.2020.09.062. Epub 2020 Dec 23. PMID: 33358653.
Third Generation Balloon and Self-Expandable Valves for Aortic Stenosis in Large and Extra-Large Aortic Annuli from the TAVR-LARGE Registry
Armijo G, Tang G, Kooistra N, Ferreira-Neto A, Toggweiler S, Amat-Santos I, Keller L, Urena M, Ahmad H, Tafur Soto J, Munoz-Garcia E, Regueiro A, Leenders G, Tirado-Conte G, Sengupta A, McInerney A, Couture T, Cuevas Herreros O, Rodriguez-Gabella T, Kini A, Ahmed M, Zaid S, Gonzalo N, Nunez-Gil I, Munoz-Garcia A, Jimenez-Quevedo P, Fernandez Ortiz A, Himbert D, Nietlispach F, Stella P, Dangas G, Escaned J, Macaya C, Rodes-Cabau J, Nombela-Franco L.
Circ Cardiovasc Interv. 2020 Aug;13(8): e009047
Outcomes after Implantation of the ACURATE Neo and Portico Transcatheter Heart Valves for the Treatment of Severe Aortic Stenosis.
Keller LS, Toggweiler S, Sutsch C, Obeid S, Tanner FC, Brinkert M, Loretz L, Cuculi F, Kobza R, Ruschitzka F, Nietlispach F.
Interv Cardiol J 2020 Feb 10; Vol.6 No.1:88. doi: 10.36648/2471-8157.6.1.88
Relation of Angiography-based Quantitative Flow Ratio with Myocardial Ischemia as Assessed by 13N-ammonia Myocardial Perfusion Imaging Positron Emission Tomography
Strähl M, Schindler M, Keller LS, Holy E, Jakob P, Templin C, Maier W, Buechel RR, Kaufmann PA, Gebhard C, Stähli BE
Int J Cardiol. 2020 Apr 27. S0167-5273(20)31381-4
Valve-in-valve implantation using the ACURATE neo in degenerated aortic bioprostheses: an international multicenter analysis
Holzamer A, Kim WK, Rück A, Sathananthan J, Keller L, Cosma J, Bauer P, Nef H, Amat-Santos IJ, Brinkert M, Husser O, Pellegrini C, Schofer J, Nerla R, Montorfano M, Giannini F, Stella P, Kuwata S, Hilker M, Castriota F, Ussia GP, Webb JG, Nietlispach F, Toggweiler S
JACC Cardiovasc Interv. 2019 Nov 25;12(22):2309-231
Baseline Predictors of Renal Failure in Transcatheter Aortic Valve Implantation
Langfritz M, Shahin M, Nietlispach F, Taramasso M, Denegri A, Moccetti M, Pedrazzini G, Moccetti T, Keller LS, Ruschitzka F, Maisano F, Obeid S
J Invasive Cardiol. 2019 Oct;31(10)E289-E297
Safety and Efficacy of Transcatheter Aortic Valve Replacement With Continuation of Oral Anticoagulation
Brinkert M, Keller LS, Moriyama N, Cuculi F, Bossard M, Lehnick D, Kobza R, Laine M, Nietlispach F, Toggweiler S
J Am Coll Cardiol. 2019 Apr 23;73(15)
A rare Cause of Syncope (2017)
Keller LS, Keller DI
Praxis, 106, pp. 1291-1293
Fortgeschrittene Post-Polycythaemia-vera-Myelofibrose (2014)
Keller L, Hüsser R, Braschler T, Gschwend A, Vogt M
Schweiz. Med. Forum 14(38): 709-711
MAGE-C2/CT10 Protein Expression is an Independent Predictor of Recurrence in Prostate Cancer (2011)
von Boehmer L, Keller L, Mortezavi A, Provenzano M, Sais G, Hermanns G, Sulser T, Jungbluth AA, Old LJ, Kristiansen G, van den Broek M, Moch H, Knuth A, Wild PJ
PLoS ONE 6(7): e21366, doi: 10.1371/journal.pone.0021366